Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
132M
-
Number of holders
-
233
-
Total 13F shares, excl. options
-
64.4M
-
Shares change
-
+6.39M
-
Total reported value, excl. options
-
$6.73B
-
Value change
-
+$671M
-
Put/Call ratio
-
1.31
-
Number of buys
-
147
-
Number of sells
-
-79
-
Price
-
$104.42
Significant Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q1 2015
273 filings reported holding ALNY - ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK as of Q1 2015.
ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) has 233 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.4M shares
of 132M outstanding shares and own 49% of the company stock.
Largest 10 shareholders include FMR LLC (12.6M shares), WELLINGTON MANAGEMENT GROUP LLP (10.4M shares), VANGUARD GROUP INC (4.33M shares), Capital World Investors (2.14M shares), UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (1.77M shares), BlackRock Institutional Trust Company, N.A. (1.76M shares), GILDER GAGNON HOWE & CO LLC (1.75M shares), BlackRock Fund Advisors (1.69M shares), MORGAN STANLEY (1.4M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1.26M shares).
This table shows the top 233 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.